Clinical considerations for the management of xylazine overdoses and xylazine‐related wounds.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Works matching IS 09652140 AND DT 2024 AND VI 119 AND IP 4
Results: 27
1
2
Nitrous oxide addiction or not, action is needed. A response to commentaries.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 627, doi. 10.1111/add.16457
- By:
- Publication type:
- Article
3
Performance of International Classification of Disease‐10 codes in detecting emergency department patients with opioid misuse.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 766, doi. 10.1111/add.16394
- By:
- Publication type:
- Article
4
NEW BOOKS.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 790, doi. 10.1111/add.16455
- Publication type:
- Article
5
Do medications increase the efficacy of digital interventions for smoking cessation? Secondary results from the iCanQuit randomized trial.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 664, doi. 10.1111/add.16396
- By:
- Publication type:
- Article
6
Changes to Our Editorial Team.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 604, doi. 10.1111/add.16445
- Publication type:
- Article
7
Commentary on Petrilli et al.: Assessing cannabis use in real‐world settings ‐ advances using standard THC units.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 784, doi. 10.1111/add.16440
- By:
- Publication type:
- Article
8
Response to Hall et al.: Prescription psychostimulants for amphetamine‐type stimulant use disorder ‐ acknowledging challenges but not giving up on its potential cost‐effectiveness.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
9
Yes, nitrous oxide addiction undeniably exists!
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 625, doi. 10.1111/add.16430
- By:
- Publication type:
- Article
10
Nitrous oxide: The label 'potentially addictive' may do more harm than good.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 623, doi. 10.1111/add.16426
- By:
- Publication type:
- Article
11
Nitrous oxide: A difficult case for classification as an addictive substance.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 621, doi. 10.1111/add.16419
- By:
- Publication type:
- Article
12
Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders?
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
13
Distributions of alcohol use and alcohol‐caused death and disability in Canada: Defining alcohol harm density functions and new perspectives on the prevention paradox.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 696, doi. 10.1111/add.16414
- By:
- Publication type:
- Article
14
Smoking, vaping and drinking: A qualitative analysis of Aotearoa New Zealand young adults who tried e‐cigarettes to stop smoking tobacco.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 686, doi. 10.1111/add.16413
- By:
- Publication type:
- Article
15
Longitudinal trajectories of substance use disorder treatment use: A latent class growth analysis using a national cohort in Chile.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 753, doi. 10.1111/add.16412
- By:
- Publication type:
- Article
16
It is time to take nitrous oxide seriously without waiting for more evidence of harms.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 619, doi. 10.1111/add.16410
- By:
- Publication type:
- Article
17
Enhanced cannabis timeline followback (EC‐TLFB): Comprehensive assessment of cannabis use including standard THC units and validation through biological measures.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 772, doi. 10.1111/add.16405
- By:
- Publication type:
- Article
18
Health and economic burden of low back pain and rheumatoid arthritis attributable to smoking in 192 countries and territories in 2019.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 677, doi. 10.1111/add.16404
- By:
- Publication type:
- Article
19
An on‐line school‐based substance use harm reduction programme: The Illicit Project randomized controlled trial results.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 741, doi. 10.1111/add.16403
- By:
- Publication type:
- Article
20
Health‐care resource use among patients who use illicit opioids in England, 2010–20: A descriptive matched cohort study.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 730, doi. 10.1111/add.16401
- By:
- Publication type:
- Article
21
Effectiveness of culturally tailoring smoking cessation interventions for reducing or quitting combustible tobacco: A systematic review and meta‐analyses.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 629, doi. 10.1111/add.16400
- By:
- Publication type:
- Article
22
Evaluation of the effectiveness of cytisine for the treatment of smoking cessation: A systematic review and meta‐analysis.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 649, doi. 10.1111/add.16399
- By:
- Publication type:
- Article
23
Efficacy and safety of short‐term edaravone or nerve growth factor add‐on therapy for alcohol‐related brain damage: A multi‐centre randomised control trial.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 717, doi. 10.1111/add.16398
- By:
- Publication type:
- Article
24
Disentangling the contributions of alcohol use disorder and alcohol‐related liver disease towards dementia: A population‐based cohort study.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 706, doi. 10.1111/add.16395
- By:
- Publication type:
- Article
25
Does nitrous oxide addiction exist? An evaluation of the evidence for the presence and prevalence of substance use disorder symptoms in recreational nitrous oxide users.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 609, doi. 10.1111/add.16380
- By:
- Publication type:
- Article
26
Issue Information.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 792, doi. 10.1111/add.16239
- Publication type:
- Article
27
Issue Information.
- Published in:
- Addiction, 2024, v. 119, n. 4, p. 601, doi. 10.1111/add.16238
- Publication type:
- Article